Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VUDALIMAB for Prostate cancer: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 5 adverse event reports in the FDA FAERS database where VUDALIMAB was used for Prostate cancer.

Most Reported Side Effects for VUDALIMAB

Side Effect Reports % Deaths Hosp.
Anaemia 21 31.8% 3 19
C-reactive protein increased 20 30.3% 7 20
Pyrexia 18 27.3% 0 16
Malignant neoplasm progression 13 19.7% 5 11
Pneumonia 13 19.7% 2 13
Dyspnoea 12 18.2% 1 11
Nausea 12 18.2% 6 11
Platelet count decreased 12 18.2% 1 10
Hypoxia 10 15.2% 2 10
Vomiting 10 15.2% 0 10
Abdominal pain 9 13.6% 7 9
Asthenia 9 13.6% 0 8
Fatigue 9 13.6% 1 6
Hypotension 9 13.6% 1 9
Blood creatinine increased 8 12.1% 0 8

Other Indications for VUDALIMAB

Non-small cell lung cancer (37) Adenocarcinoma (18)

Other Drugs Used for Prostate cancer

LEUPROLIDE (45,399) ENZALUTAMIDE (25,954) RELUGOLIX (18,752) ABIRATERONE (12,209) APALUTAMIDE (3,286) GOSERELIN (2,080) DEGARELIX (2,035) BICALUTAMIDE (1,832) SIPULEUCEL-T (1,720) DENOSUMAB (1,627)

Related Pages

VUDALIMAB Full Profile All Prostate cancer Drugs VUDALIMAB Demographics VUDALIMAB Timeline